ZeroNorth and Alpha Ori Technologies Announce Plan to Join Forces, Boosting Fuel and Efficiency Optimisation Options Across the Global Shipping Fleet
30.10.2023 10:54:00 CET | Business Wire | Press Release
ZeroNorth and Alpha Ori Technologies (AOT) have announced today that they intend to join forces in an agreement that will create a leading maritime optimisation company and a new powerhouse in shipping’s digital transformation.
Subject to regulatory approval, the two companies plan to generate synergies by combining Alpha Ori Technologies' expertise in IoT sensors and high frequency data and ZeroNorth's multi-service technology platform to create new sustainability solutions for shipping. The agreement will allow the two companies to serve their customer bases from a single offering and create a strong data ecosystem on one platform with multiple services within the market.
The company intends to operate under the ZeroNorth brand and Søren Meyer, ZeroNorth’s current CEO, will remain at the helm of the joint set-up. Both of AOT’s current Co-CEOs, Bala Sankaran and Rajesh Unni, will become non-executive board members of the joint business.
The two proposed partners already supply cutting-edge technology to more than 4000 ships trading globally. The agreement will enable customers to access 12 different services using one platform and one data source. This will help to significantly advance industry developments and policy efforts across the global trade value chain.
ZeroNorth will interconnect data, providing collection, insights, and analysis, which will enhance quality and compliance for customers. By unlocking operational efficiencies and increasing reliability, customers will also benefit from cost savings, increased profits, and emissions reduction.
The joint business will remain an independent company with robust financial backing and heritage from top industry leaders, leveraging their deep shipping knowledge to deliver transformative solutions that positively impact the sector.
The company will retain its global office presence, headquartered from Copenhagen, and a combined workforce of 780 people, approximately one third of which are full-time consultants, will work together to create significant further impact on the planet.
Speaking on the announcement, Søren Meyer, CEO, ZeroNorth said: “I am delighted to be able to announce this agreement with Alpha Ori Technologies, which we truly believe represents the exciting next step in shipping’s digital and sustainability transformation. This is a strategic move that will not just benefit our customers, but the sector as a whole. It will enable us to serve the industry as its leading maritime optimisation provider of choice and underlines our commitment to bettering both profit and planet.”
“ZeroNorth and Alpha Ori Technologies chose each other because of our shared values and common mission to drive impactful change for shipping and the wider global trade value chain. The combined ecosystem that this partnership will create will enable us to touch from shore to ship and back to shore.”
“It will accelerate our technology development, strengthen our innovative mindset, and enable us to continue to help our customers focus on profit and planet in an increasingly complex and volatile world.”
Bala Sankaran, Co-CEO Alpha Ori Technologies, added: “Joining forces with ZeroNorth secures a market leading position for our companies, and enables us to propel the industry towards greater profitability and sustainability outcomes. We believe that this is the perfect time for us to scale and do bigger things together, and this agreement is perfectly in line with our ambition to drive sustainability, performance, and business results for our customers.”
“ZeroNorth is an ideal fit for AOT's ambitions regarding digital transformation of the Maritime industry due to our considerable expertise and specialism in high frequency data. The agreement with ZeroNorth brings significant advantages, enabling us to leverage our combined scale for increased investment and improved customer value.”
ZeroNorth has already helped its customers to collectively cut their emissions by more than one million metric tonnes since 2021. The agreement will help to further improve the positive momentum both companies are enabling within the global trade value chain.
About ZeroNorth
Recognising the challenges posed by climate change, technology company ZeroNorth was founded to accelerate the transition to greener global trade. By blending cutting-edge data-driven technology with human expertise, the ZeroNorth platform provides a range of software solutions that are helping the global shipping industry cut emissions and reduce its impact on the climate, whilst maintaining commercial performance.
ZeroNorth offers one platform with multiple services and is an industry leading software developer, which interconnects data into insights and actions, optimising global trade for cargo owners, vessel owners, commercial operators, charterers, and bunker suppliers. The company’s software offers a full range of services which support the value chain to increase earnings and reduce CO2 emissions.
For more information, please visit: www.zeronorth.com
About Alpha Ori Technologies
Alpha Ori Technologies (AOT) is a B2B Technology company headquartered in Singapore with overseas product development offices in India and the United States. Alpha Ori’s vision is to digitally enable all floating enterprises with cutting-edge technologies – IoT, Machine Learning and Cloud-based Big Data science – to drive remote operations, enhance operational efficiency and achieve the highest levels of safety on board ships.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231030734807/en/
Contact information
For media requests:
Sarah Bogue
Director of Communications and Brand
ZeroNorth
+45 31 20 69 13
sarah.bogue@zeronorth.com
Lora Jakobsen
Head of Communications and Marketing
ZeroNorth
+45 60872882
lora.jakobsen@zeronorth.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press Release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press Release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press Release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press Release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom